Tracheoesophageal fistula developing during chemotherapy for non-Hodgkins lymphoma.
Lymphoma is an unusual cause of tracheoesophageal fistula (TEF). Most fistulas develop after radiation therapy and are a rare occurrence in patients treated with chemotherapy alone. The presence of a TEF is usually indicative of active lymphoma. This report describes a tracheoesophageal fistula that developed during chemotherapy for diffuse large cell lymphoma.
Lackner
R P
RP
Department of Surgery, University of Nebraska Medical Center, Omaha 68198-2315, USA.
Bierman
P J
PJ
Galbraith
T A
TA
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000008:administration & dosage; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000150:complications* / Q000188:drug therapy; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D014057:Tomography, X-Ray Computed; D014138:Tracheoesophageal Fistula / Q000000981:diagnostic imaging / Q000209:etiology* / Q000601:surgery; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D003520:Cyclophosphamide; D008942:Mitoxantrone; D011241:Prednisone